Home
About
Portfolio
Meet the Team
News
Contact
Investor Portal

info@chv.vc
129 South Street, 4th Floor, Boston, MA 02111

Home / Portfolio / EyeCool Therapeutics

EyeCool Therapeutics

EyeCool Therapeutics is developing a novel device-based solution for the treatment of dry eye.

Status

Active

CHV Lead

Joshua Phillips

Related News & Links

Let’s Connect.

Sitemap

Home
About
Portfolio
Meet the Team
News
Contact
Investor Portal

About

Catalyst Health Ventures (CHV) is a venture capital fund investing in transformative medical technologies addressing global unmet needs.

Contact

info@chv.vc

Boston Web Design by GoingClear